Last reviewed · How we verify

NCT06329154

Clinical Study On Extracorporeal Shock Wave Therapy For Rotator Cuff Injuries

Status unknown NA Last updated 25 March 2024
What this trial tests

NA trial testing Extracorporeal shock wave therapy in Rotator Cuff Injuries in 58 participants. Status unknown.

Timeline
27 February 2024
Primary endpoint
27 January 2025
27 February 2025

Quick facts

Lead sponsorYong Liu, MD
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment58
Start date27 February 2024
Primary completion27 January 2025
Estimated completion27 February 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Yong Liu, MD

Who can join

Adults 20 to 80, any sex, with Rotator Cuff Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial aims to learn about the effect of extracorporeal shock wave therapy on rotator cuff injuries. The main question it aims to answer is the efficacy of extracorporeal shock wave therapy on the improvement of pain, shoulder function, and quality of life in patients with rotator cuff injuries. The experimental group of patients received extracorporeal shock wave therapy combined with conventional rehabilitation therapy. The control group only received conventional rehabilitation therapy. Compare the two groups to explore the therapeutic effect of extracorporeal shock wave therapy on rotator cuff injuries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Extracorporeal shock wave therapy

Trials testing the same drug.

Other recruiting trials for Rotator Cuff Injuries

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06329154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing